GSE212057 SIRT6 overexpression 4 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE212057_SIRT6 overexpression_4_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE212057_SIRT6 overexpression_4_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE212057_SIRT6 overexpression_4_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE212057_SIRT6 overexpression_4_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

tripartite motif containing 16 like (pseudogene)

Gene

uncharaterized LOC112694756

Gene

dehydrogenase/reductase X-linked

Gene

mitochondrial rRNA methyltransferase 1

Gene

taxilin gamma Y-linked (pseudogene)

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

PRKCQ antisense RNA 1

Gene

MIR4458 host gene

Gene

MIR193b-365a host gene

  • Gene

    DExD-box helicase 52


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    uncharaterized LOC112694756


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    mitochondrial rRNA methyltransferase 1


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    PRKCQ antisense RNA 1



  • Gene

    MIR193b-365a host gene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.